Imatinib mesylate: An attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans
Victoria Price(University of Toronto), Alberto S. Pappo(St. Jude Children's Research Hospital), Maria Zieleńska(University of Toronto), Jonathan A. Fletcher(Harvard University), Mary Stuart(University of Toronto), Sandra Viero(University of Toronto), William G. Cole(Hospital for Sick Children), David Manson(University of Toronto)
Cited by 92
Related Papers
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647